دورية أكاديمية
أعرض في EDS

Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

التفاصيل البيبلوغرافية
العنوان: Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.
المؤلفون: de Almeida Júnior JN; Central Laboratory Division-LIM03, Faculdade de Medicina da Universidade de São PauloSão Paulo, Brazil; Laboratory of Medical Mycology-LIM53, Instituto de Medicina Tropical da Universidade de São PauloSão Paulo, Brazil., Hennequin C; Service de Parasitologie-Mycologie-AP-HP, Hôpital St AntoineParis, France; Institut National de la Santé et de la Recherche Médicale UMR 1135, Centre National de la Recherche Scientifique ERL 8255, Sorbonne Universités, University Pierre and Marie Curie (UPMC)Paris, France; Centre d'Immunologie et des Maladies Infectieuses, Bd de l'hôpitalParis, France.
المصدر: Frontiers in microbiology [Front Microbiol] 2016 Oct 17; Vol. 7, pp. 1629. Date of Electronic Publication: 2016 Oct 17 (Print Publication: 2016).
نوع المنشور: Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Research Foundation
مستخلص: Objectives: This review aimed to better depict the clinical features and address the issue of therapeutic management of Trichosporon deep-seated infections. Methods: We comprehensively reviewed the cases of invasive Trichosporon infection reported in the literature from 1994 (date of taxonomic modification) to 2015. Data from antifungal susceptibility testing (AST) studies were also analyzed. Results: Two hundred and three cases were retained and split into four groups: homeopathy ( n = 79), other immunodeficiency conditions ( n = 41), miscellaneous ( n = 58) and newborns ( n = 25). Trichosporon asahii was the main causative species (46.7%) and may exhibit cross-resistance to different antifungal classes. The unfavorable outcome rate was at 44.3%. By multivariate analysis, breakthrough infection (OR 2.45) was associated with unfavorable outcome, whilst the use of an azole-based therapy improved the prognosis (OR 0.16). Voriconazole-based treatment was associated with favorable outcome in hematological patients (73.6 vs. 41.8%; p = 0.016). Compiled data from AST demonstrated that (i) T. asahii exhibits the highest MICs to amphotericin B and (ii) voriconazole has the best in vitro efficacy against clinical isolates of Trichosporon spp. Conclusions: Trichosporon infection is not only restricted to hematological patients. Analysis of compiled data from AST and clinical outcome support the use of voriconazole as first line therapy.
References: Med Mycol. 2011 Apr;49(3):306-10. (PMID: 20950223)
Singapore Med J. 2007 Mar;48(3):256-8. (PMID: 17342297)
Med Mycol Case Rep. 2015 Jul 02;9:12-4. (PMID: 26199866)
Antimicrob Agents Chemother. 2002 Apr;46(4):1144-6. (PMID: 11897610)
Clin Nephrol. 2003 Jan;59(1):69-70. (PMID: 12572937)
Int J Hematol. 2008 Dec;88(5):588-95. (PMID: 19039629)
Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):139-42. (PMID: 11305471)
Clin Infect Dis. 2003 Feb 15;36(4):E63-6. (PMID: 12567323)
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. (PMID: 18462102)
J Clin Microbiol. 2011 Dec;49(12):4405-8. (PMID: 22012010)
Rev Inst Med Trop Sao Paulo. 2012 Jan-Feb;54(1):1-3. (PMID: 22370746)
Rev Iberoam Micol. 2003 Dec;20(4):121-36. (PMID: 15456349)
Transpl Infect Dis. 2015 Aug;17(4):605-9. (PMID: 26094645)
Medicine (Baltimore). 1986 Jul;65(4):268-79. (PMID: 3523114)
Scand J Infect Dis. 2002;34(2):143-4. (PMID: 11928852)
J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):620-3. (PMID: 14581808)
Clin Microbiol Infect. 2014 Aug;20(8):777-83. (PMID: 24330082)
Pediatr Infect Dis J. 2008 Nov;27(11):1035-7. (PMID: 18845986)
Burns. 2000 Aug;26(5):483-6. (PMID: 10812273)
J Pediatr (Rio J). 1995 Nov-Dec;71(6):341-3. (PMID: 14688985)
J Korean Med Sci. 2001 Aug;16(4):505-8. (PMID: 11511798)
Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):47-51. (PMID: 25798156)
Clin Infect Dis. 1995 Apr;20(4):913-6. (PMID: 7795094)
Indian J Pathol Microbiol. 2015 Apr-Jun;58(2):246-8. (PMID: 25885147)
J Assoc Physicians India. 2000 Oct;48(10):1022-4. (PMID: 11200905)
Med Mycol. 2002 Feb;40(1):83-6. (PMID: 11862981)
J Antimicrob Chemother. 2002 Feb;49(2):415-9. (PMID: 11815592)
Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):843-5. (PMID: 17690928)
Antimicrob Agents Chemother. 2005 Oct;49(10):4026-34. (PMID: 16189076)
Retin Cases Brief Rep. 2010 Fall;4(4):366-7. (PMID: 25390919)
Pediatr Infect Dis J. 1995 Dec;14(12):1110-3. (PMID: 8745028)
Nephrol Dial Transplant. 1999 Aug;14(8):2017-8. (PMID: 10462290)
Infect Control Hosp Epidemiol. 2013 Jun;34(6):638-41. (PMID: 23651898)
J Miss State Med Assoc. 2011 Nov;52(11):339-43. (PMID: 22372158)
Ther Clin Risk Manag. 2014 Sep 30;10:759-62. (PMID: 25328390)
J Clin Microbiol. 2009 Oct;47(10):3091-7. (PMID: 19656976)
Transpl Infect Dis. 2012 Apr;14(2):184-7. (PMID: 22093149)
Clin Kidney J. 2012 Oct;5(5):459-462. (PMID: 23936627)
Haematologica. 1992 Nov-Dec;77(6):522-3. (PMID: 1289191)
Clin Microbiol Infect. 2014 Aug;20(8):784-90. (PMID: 24355037)
Int J Infect Dis. 2015 Oct;39:87-8. (PMID: 26376224)
J Clin Microbiol. 2006 Mar;44(3):1175-7. (PMID: 16517924)
Diagn Microbiol Infect Dis. 2002 Jun;43(2):167-70. (PMID: 12088626)
Leuk Lymphoma. 2006 Jun;47(6):1182-3. (PMID: 16840220)
Indian J Med Microbiol. 2014 Jan-Mar;32(1):72-4. (PMID: 24399394)
J Infect. 1998 Jan;36(1):120-1. (PMID: 9515683)
Mycoses. 2001;44(1-2):13-21. (PMID: 11398636)
J Chemother. 1997 Dec;9(6):427-30. (PMID: 9491843)
Ann Thorac Cardiovasc Surg. 2009 Oct;15(5):350-3. (PMID: 19901894)
Abdom Imaging. 2004 Mar-Apr;29(2):228-30. (PMID: 15290951)
J Infect. 2012 Jan;64(1):68-75. (PMID: 22101079)
Acta Derm Venereol. 1994 Nov;74(6):481-2. (PMID: 7701893)
J Clin Microbiol. 2001 Dec;39(12):4420-5. (PMID: 11724855)
Cancer. 1981 Nov 15;48(10):2163-7. (PMID: 7296474)
Antimicrob Agents Chemother. 2013 Oct;57(10):4841-7. (PMID: 23877683)
Ulster Med J. 2006 Sep;75(3):226-7. (PMID: 16964817)
Med Mycol. 2008 Nov;46(7):719-23. (PMID: 18651307)
Rev Iberoam Micol. 2006 Jun;23(2):85-9. (PMID: 16854183)
Microbiol Immunol. 2011 Jul;55(7):483-8. (PMID: 21707737)
Perit Dial Int. 2008 Jan-Feb;28(1):100-1. (PMID: 18178957)
Bone Marrow Transplant. 2011 Feb;46(2):310-1. (PMID: 20436525)
JAMA Dermatol. 2015 Jun;151(6):642-5. (PMID: 25785367)
Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):604-6. (PMID: 7805691)
Jpn J Infect Dis. 2006 Apr;59(2):129-31. (PMID: 16632916)
Clin Infect Dis. 1996 Aug;23(2):396-7. (PMID: 8842284)
Ann Dermatol Venereol. 1998 Feb;125(2):111-3. (PMID: 9747226)
Open Forum Infect Dis. 2015 Sep 25;2(4):ofv141. (PMID: 26566536)
Can J Infect Dis Med Microbiol. 2008 Mar;19(2):203-5. (PMID: 19352453)
Eur J Dermatol. 1999 Oct-Nov;9(7):577-9. (PMID: 10523742)
Mycoses. 2015 Feb;58(2):99-103. (PMID: 25590228)
J Glob Infect Dis. 2009 Jan;1(1):71-4. (PMID: 20300392)
Transplant Proc. 2011 Mar;43(2):657-9. (PMID: 21440787)
J Microbiol Immunol Infect. 2016 Feb;49(1):146-9. (PMID: 23419599)
Am J Perinatol. 1997 Feb;14(2):113-7. (PMID: 9259910)
Pediatr Infect Dis J. 2002 Feb;21(2):169-70. (PMID: 11840088)
Rev Bras Ter Intensiva. 2008 Mar;20(1):106-9. (PMID: 25306958)
PLoS One. 2014 Oct 31;9(10):e109553. (PMID: 25360765)
Int J Hematol. 2007 Jun;85(5):415-7. (PMID: 17562617)
Clin Exp Dermatol. 2003 Jan;28(1):37-8. (PMID: 12558627)
Antimicrob Agents Chemother. 2014;58(2):865-73. (PMID: 24277033)
Spine (Phila Pa 1976). 2008 Feb 15;33(4):E116-20. (PMID: 18277860)
Diagn Microbiol Infect Dis. 2002 Sep;44(1):17-22. (PMID: 12376026)
J Clin Microbiol. 2003 Dec;41(12 ):5827-9. (PMID: 14662994)
Mycopathologia. 2012 Aug;174(2):121-30. (PMID: 22318636)
Infection. 2008 Feb;36(1):68-70. (PMID: 17882360)
Clin Microbiol Rev. 2011 Oct;24(4):682-700. (PMID: 21976604)
Nephrol Dial Transplant. 1994;9(11):1658-9. (PMID: 7870361)
J R Soc Med. 1994 May;87(5):292-3. (PMID: 8207729)
Transpl Infect Dis. 2009 Apr;11(2):155-9. (PMID: 18983414)
Med Mycol. 2015 Jun;53(5):505-11. (PMID: 25980003)
Support Care Cancer. 1999 Jan;7(1):39-43. (PMID: 9926973)
Mycoses. 2006 May;49(3):251-3. (PMID: 16681821)
South Med J. 2005 Sep;98(9):954-5. (PMID: 16217998)
J Formos Med Assoc. 1995 Mar;94(3):127-31. (PMID: 7613244)
Clin Infect Dis. 2001 Sep 1;33(5):E28-30. (PMID: 11477533)
J Med Microbiol. 2012 Dec;61(Pt 12):1750-7. (PMID: 22956749)
Mycopathologia. 1997;139(1):15-8. (PMID: 9511232)
Southeast Asian J Trop Med Public Health. 2014 Mar;45(2):421-9. (PMID: 24968684)
Diagn Microbiol Infect Dis. 2002 Jun;43(2):107-11. (PMID: 12088616)
Neurol Neurochir Pol. 2012 Jan-Feb;46(1):92-5. (PMID: 22426768)
Int J Hematol. 2007 Feb;85(2):177-8. (PMID: 17322000)
J Chemother. 2005 Aug;17(4):404-8. (PMID: 16167520)
Clin Microbiol Infect. 2014 Apr;20 Suppl 3:76-98. (PMID: 24102785)
J Clin Microbiol. 2002 May;40(5):1826-30. (PMID: 11980969)
J Clin Microbiol. 2012 Dec;50(12 ):4168-70. (PMID: 23035187)
Retina. 2003 Jun;23(3):404-5. (PMID: 12824845)
Eur J Haematol. 2015 Mar;94(3):258-64. (PMID: 25082655)
J Infect. 2006 Sep;53(3):e135-8. (PMID: 16434103)
Braz J Microbiol. 2008 Jul;39(3):585-92. (PMID: 24031270)
Clin Infect Dis. 1998 Apr;26(4):999-1000. (PMID: 9564494)
J Pediatr (Rio J). 2009 Sep-Oct;85(5):459-61. (PMID: 19830348)
Transpl Infect Dis. 2014 Feb;16(1):135-40. (PMID: 24383613)
Antimicrob Agents Chemother. 2011 Apr;55(4):1563-70. (PMID: 21245438)
N Engl J Med. 2001 Dec 6;345(23):1660-6. (PMID: 11759644)
J Antimicrob Chemother. 2004 Aug;54(2):575-7. (PMID: 15231763)
Indian Pediatr. 2012 Sep;49(9):745-7. (PMID: 23024079)
Scand J Infect Dis. 2004;36(8):564-9. (PMID: 15370667)
J Pediatr Hematol Oncol. 2005 May;27(5):283-5. (PMID: 15891566)
J Pediatr Hematol Oncol. 2008 Dec;30(12):917-9. (PMID: 19131780)
Cardiovasc Surg. 1994 Feb;2(1):119-23. (PMID: 8049917)
Rev Iberoam Micol. 2015 Jan-Mar;32(1):59-61. (PMID: 24071639)
Clin Infect Dis. 2006 Aug 15;43(4):e39-41. (PMID: 16838224)
Med Mycol. 2014 May;52(4):356-66. (PMID: 24682113)
Mycoses. 2002 Apr;45(3-4):123-5. (PMID: 12000516)
Eur J Clin Microbiol Infect Dis. 2002 Dec;21(12):892-6. (PMID: 12525928)
Bone Marrow Transplant. 2000 Apr;25(7):745-9. (PMID: 10745260)
Med Mycol Case Rep. 2014 Oct 19;6:55-7. (PMID: 25383317)
Am J Perinatol. 2003 Jul;20(5):269-71. (PMID: 13680511)
J Clin Microbiol. 2005 Apr;43(4):1818-28. (PMID: 15815003)
Infection. 1994 Jul-Aug;22(4):283-6. (PMID: 7528173)
J Clin Microbiol. 2003 Nov;41(11):5317-20. (PMID: 14605194)
Eur J Haematol. 2010 May;84(5):441-7. (PMID: 20059528)
Eur Radiol. 1998;8(6):922-4. (PMID: 9683693)
Chin Med J (Engl). 2012 Jul;125(14 ):2632-5. (PMID: 22882952)
Clin Microbiol Infect. 1997 Aug;3(4):509-510. (PMID: 11864171)
Pathol Int. 2006 Dec;56(12):738-43. (PMID: 17096731)
Diagn Microbiol Infect Dis. 2007 Aug;58(4):435-40. (PMID: 17509802)
Pediatr Hematol Oncol. 2014 Apr;31(3):282-4. (PMID: 24383917)
J Clin Microbiol. 2004 May;42(5):2341-4. (PMID: 15131229)
J Clin Microbiol. 2009 Jun;47(6):1791-9. (PMID: 19321719)
Diagn Microbiol Infect Dis. 2001 Mar;39(3):161-4. (PMID: 11337182)
Am J Respir Crit Care Med. 2011 Oct 15;184(8):982. (PMID: 22003150)
Burns. 1994 Oct;20(5):467-8. (PMID: 7999281)
Cancer. 1986 Dec 1;58(11):2399-405. (PMID: 3533246)
Clin Infect Dis. 2009 Nov 1;49(9):1457-8. (PMID: 19824853)
J Perinatol. 2004 May;24(5):324-6. (PMID: 15116131)
AIDS. 2008 Mar 30;22(6):793-5. (PMID: 18356615)
J Clin Microbiol. 2009 Jan;47(1):117-23. (PMID: 19005141)
Case Rep Infect Dis. 2015;2015:651315. (PMID: 26351595)
Indian J Pathol Microbiol. 2002 Jul;45(3):337-9. (PMID: 12785180)
Mycoses. 1996 May-Jun;39(5-6):195-9. (PMID: 8909029)
Mycoses. 1995 Mar-Apr;38(3-4):125-6. (PMID: 7477087)
J Microbiol Immunol Infect. 2006 Oct;39(5):426-9. (PMID: 17066207)
Rev Inst Med Trop Sao Paulo. 1994 Mar-Apr;36(2):121-3. (PMID: 7997786)
Braz J Microbiol. 2010 Apr;41(2):310-5. (PMID: 24031497)
Perit Dial Int. 2013 May-Jun;33(3):341-2. (PMID: 23660618)
Transpl Infect Dis. 2005 Sep-Dec;7(3-4):162-5. (PMID: 16390408)
Clin Cardiol. 1994 Apr;17(4):215-9. (PMID: 8187373)
Cancer. 1998 Feb 1;82(3):484-7. (PMID: 9452265)
Mycopathologia. 2010 Jan;169(1):67-70. (PMID: 19609716)
Eur J Clin Microbiol Infect Dis. 1995 Feb;14(2):148-9. (PMID: 7758485)
Pediatr Infect Dis J. 2000 Oct;19(10):1025-7. (PMID: 11055614)
Lancet. 1985 Jul 6;2(8445):43-4. (PMID: 2861489)
Clin Infect Dis. 2002 Jul 15;35(2):e22-5. (PMID: 12087540)
Pathog Glob Health. 2015 Jun;109(4):202-6. (PMID: 26039332)
Arch Pathol Lab Med. 1994 Feb;118(2):191-4. (PMID: 8311664)
J Antimicrob Chemother. 2009 Jul;64(1):79-83. (PMID: 19406849)
Arq Bras Oftalmol. 2015 Jul-Aug;78(4):252-4. (PMID: 26375343)
Ann Clin Lab Sci. 2007 Autumn;37(4):366-9. (PMID: 18000295)
Mycopathologia. 2011 Apr;171(4):279-83. (PMID: 20862548)
Ann Biol Clin (Paris). 2010 May-Jun;68(3):363-6. (PMID: 20478783)
Indian J Med Microbiol. 2015 Oct-Dec;33(4):576-9. (PMID: 26470968)
Bone Marrow Transplant. 2014 Sep;49(9):1212-6. (PMID: 25000455)
Clin Infect Dis. 1992 Nov;15(5):781-7. (PMID: 1445976)
J Clin Microbiol. 1990 Jul;28(7):1616-22. (PMID: 2380383)
J Am Acad Dermatol. 2008 Aug;59(2 Suppl 1):S13-5. (PMID: 18625370)
J Clin Microbiol. 2009 Apr;47(4):1074-81. (PMID: 19225102)
J Clin Microbiol. 2011 Nov;49(11):3805-11. (PMID: 21900517)
Clin Infect Dis. 2006 Mar 15;42(6):753-7. (PMID: 16477548)
Indian J Med Microbiol. 2004 Jan-Mar;22(1):16-22. (PMID: 17642680)
Pediatr Infect Dis J. 2002 Feb;21(2):161-5. (PMID: 11840086)
J Microbiol Immunol Infect. 2010 Feb;43(1):77-80. (PMID: 20434128)
J Allergy Clin Immunol. 2004 Dec;114(6):1418-24. (PMID: 15577847)
Med Mycol. 2013 Nov;51(8):880-3. (PMID: 23768241)
Mycoses. 1994 Jan-Feb;37(1-2):3-10. (PMID: 7935589)
فهرسة مساهمة: Keywords: Trichosporon species; antifungal resistance; diagnosis; invasive infection; prognosis; risk factors; treatment
تواريخ الأحداث: Date Created: 20161102 Latest Revision: 20220321
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC5065970
DOI: 10.3389/fmicb.2016.01629
PMID: 27799926
قاعدة البيانات: MEDLINE
الوصف
تدمد:1664-302X
DOI:10.3389/fmicb.2016.01629